Pain Management · Atlanta, GA
NPI
1356427850
Since 2006
Specialty
Pain Management
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3193 Howell Mill Rd NW, Ste. #317
Atlanta, GA, 30327
Phone (404) 603-9090
Groups this clinician bills Medicare through
Medicare paid, 2024
$226K
5,240 services
Medicare patients, 2024
390
Average age 70
Drug cost, 2024
$1.2M
14,156 prescriptions
Company payments, 2025
$1,507
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kamal C Kabakibou was code G0480 (drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms), 577 times for 251 patients. In total Kamal C Kabakibou billed 5,240 services in 54 codes, and Medicare paid $226K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 577 | 251 | $111.50 | $64K |
| 99213 Office E&M - Established | Office | 558 | 280 | $63.16 | $35K |
| 80307 Drug Tests | Office | 455 | 227 | $60.18 | $27K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 441 | 54 | $0.10 | $43.73 |
| 99214 Office E&M - Established | Office | 339 | 188 | $90.85 | $31K |
| 62323 Nerve Block Injection - Back | Facility | 74 | 56 | $72.60 | $5,372 |
| 99205 Office E&M - New | Office | 66 | 66 | $168.06 | $11K |
| 62369 Musculoskeletal | Office | 45 | 14 | $73.79 | $3,320 |
| 20552 Musculoskeletal | Office | 37 | 34 | $41.06 | $1,519 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 22 | 17 | $3.89 | $85.64 |
| 20610 Joint Injection | Office | 19 | 15 | $56.94 | $1,082 |
| 96372 Injection Administration | Office | 18 | 11 | $10.42 | $188 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 17 | 17 | $196.53 | $3,341 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 15 | 13 | $55.98 | $840 |
| 20611 Joint Injection | Office | 14 | 12 | $78.27 | $1,096 |
By year: 2022 $285K for 6,883 services; 2023 $218K for 5,289 services; 2024 $226K for 5,240 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 577 | 251 | $111.50 | $64K |
| 80307 Drug Tests | 455 | 227 | $60.18 | $27K |
Medicare prescription drug claims, 2024
In 2024, the drug Kamal C Kabakibou prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 2,007 prescriptions and refills. In total Kamal C Kabakibou wrote 14,156 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,007 | 2,007 | 234 | $172K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,850 | 1,858 | 227 | $48K |
| Gabapentin Generic | 1,214 | 1,351 | 178 | $14K |
| Oxycodone Hcl Generic | 1,085 | 1,085 | 115 | $19K |
| Tizanidine Hcl Generic | 692 | 787 | 104 | $6,341 |
| Cyclobenzaprine Hcl Generic | 457 | 536 | 82 | $2,803 |
| Pregabalin Generic | 412 | 456 | 67 | $6,467 |
| Morphine Sulfate Er Morphine Sulfate | 400 | 400 | 44 | $9,550 |
| Buprenorphine Hcl Generic | 344 | 354 | 48 | $8,638 |
| Tramadol Hcl Generic | 262 | 264 | 52 | $1,791 |
| Methadone Hcl Generic | 251 | 252 | 30 | $3,807 |
| Diclofenac Sodium Generic | 209 | 232 | 49 | $21K |
| Promethazine Hcl Generic | 208 | 219 | 34 | $1,200 |
| Hydromorphone Hcl Generic | 183 | 185 | 35 | $2,343 |
| Xtampza Er Oxycodone Myristate | 181 | 181 | 24 | $88K |
Brand drugs: 1,241 claims; generic drugs: 12,915 claims; opioid claims: 6,826.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kamal C Kabakibou $1,507 ($1,507 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $263.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $263 |
| Abbott Laboratories ABT | 3 | $139 |
| Globus Medical, Inc. GMED | 2 | $115 |
| UCB, Inc. UCB.BR | 4 | $109 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $90.13 |
| Lundbeck LLC | 3 | $84.55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $83.75 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $81.28 |
| Amgen Inc. AMGN | 3 | $75.92 |
| Axsome Therapeutics, Inc. AXSM | 3 | $74.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.